Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Impact of Food Distribution at Low-income Clinics on Health Outcomes of Patients With Diabetes
| Verified date | September 2016 |
| Source | University of California, San Diego |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
To compare the effectiveness of providing monthly boxes of nutritious foods to low-income patients with diabetes on site at Free Clinics with referrals to off-site food pantries on diabetes related health outcomes
| Status | Completed |
| Enrollment | 201 |
| Est. completion date | May 2016 |
| Est. primary completion date | April 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - type 2 diabetes - receiving medical care at one of the UC San Diego Student-run Free Clinic Sites Exclusion Criteria: - unable to attend monthly food distribution onsite (pt states will not able to come monthly due to any kind of conflict (work, transportation, childcare), or is not interested in coming monthly due to time or transportation burden) |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of California, San Diego |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in HbA1c (measured as part of routine care) | primary outcome measure is change in HbA1c from baseline to 3 months, 6 months, 9 months (9months is for delayed intervention only) | ||
| Secondary | Change in Food Insecurity | United States Department of Agriculture 6 item food security scale | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in Diabetes Distress | As measured by Diabetes Distress Scale | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in Fruit and Vegetable Intake | As measured by Fruit Frequency Questionnaire | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in Hypoglycemic Events | patient report of frequency of hypoglycemia by survey item | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in Medication adherence | as measured by survey item | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in Blood Pressure (systolic and diastolic) | as measured as part of routine medical care | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in LDL | as measured as part of routine medical care | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in weight (in pounds) and Body Mass Index | as measured as part of routine medical care | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) | |
| Secondary | Change in Body Mass Index, measured in kg/m^2, weight in kilograms, height in meters | as measured as part of routine medical care | baseline, 3 months, 6 months, 9 months (9 months is for delayed intervention only) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |